NCT05261763 - Clinical Trial References

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Citation(s)

Erratum: Effects of Trigger Point Dry Needling on Neuromuscular Performance and Pain of Individuals Affected by Patellofemoral Pain: A Randomized Controlled Trial [Corrigendum]
J Pain Res. 2020 Sep 7;13:2237. doi: 10.2147/JPR.S278493. eCollection 2020.
Mason JS, Crowell M, Dolbeer J, Morris J, Terry A, Koppenhaver S, Goss DL
THE EFFECTIVENESS OF DRY NEEDLING AND STRETCHING VS. STRETCHING ALONE ON HAMSTRING FLEXIBILITY IN PATIENTS WITH KNEE PAIN: A RANDOMIZED CONTROLLED TRIAL. Int J Sports Phys Ther. 2016 Oct;11(5):672-683.
Neal BS, Lack SD, Lankhorst NE, Raye A, Morrissey D, van Middelkoop M
Risk factors for patellofemoral pain: a systematic review and meta-analysis. Br J Sports Med. 2019 Mar;53(5):270-281. doi: 10.1136/bjsports-2017-098890. Epub 2018 Sep 21.

Study on the Effects of Trigger Point Dry Needling on Patients With Patello-femoral Pain Syndrome: A Randomized Controlled Trial

Clinical trial NCT05261763 - References